Behrens Lukas, Walter Ruben Magnus, Cai Weining, Ewers Helge, van Bommel Bas, Zemella Anne
Institut für Chemie und Biochemie, Freie Universität Berlin, Thielallee 63, 14195 Berlin, Germany.
Branch Bioanalytics and Bioprocesses, Fraunhofer Institute for Cell Therapy and Immunology, Am Mühlenberg 13, 14476 Potsdam, Germany.
ACS Omega. 2024 Aug 9;9(33):35374-35383. doi: 10.1021/acsomega.4c01164. eCollection 2024 Aug 20.
Small antigen binders, such as nanobodies, have become widely used in biomedical research and pharmaceutical development. However, the pipeline for the generation of functional conjugated probes and drugs from identified binders remains a major time-consuming bottleneck. Here, we developed a method for fast nanobody production and conjugation based on an in vitro synthesis platform. Our system allows for small batch synthesis of nanobodies with the inclusion of a noncanonical amino acid (NCAA). This NCAA can then be used for direct conjugation of molecules to the synthesized nanobody using click-chemistry, reducing the time from binder-encoding DNA to a conjugated probe tremendously. In this study, we conjugated a fluorescent dye to an anti-Green fluorescent protein (GFP) nanobody and attained a fully functional probe suitable for advanced super-resolution microscopy within a short time frame of 2 days. Our work illustrates that an in vitro synthesis platform in combination with click-chemistry can be successfully employed to produce conjugated small antigen binding probes. The fast production and conjugation, combined with the possibility for parallelization as well as precise analysis by microscopy, forms an excellent platform for nanobody prototyping. The here-illustrated method can be used for quick selection and benchmarking of obtained nanobody sequences/clones, e. g., from a phage-display, for use as conjugated small-molecule carriers. This procedure can accelerate the bioengineering of nanobodies for research and pharmaceutical applications.
小型抗原结合物,如纳米抗体,已在生物医学研究和药物开发中得到广泛应用。然而,从已鉴定的结合物生成功能性共轭探针和药物的流程仍然是一个主要的耗时瓶颈。在此,我们基于体外合成平台开发了一种快速生产和共轭纳米抗体的方法。我们的系统允许在包含非标准氨基酸(NCAA)的情况下小批量合成纳米抗体。然后,这种NCAA可用于通过点击化学将分子直接共轭到合成的纳米抗体上,极大地缩短了从结合物编码DNA到共轭探针的时间。在本研究中,我们将一种荧光染料共轭到抗绿色荧光蛋白(GFP)纳米抗体上,并在短短2天的时间内获得了适用于先进超分辨率显微镜的全功能探针。我们的工作表明,体外合成平台与点击化学相结合可成功用于生产共轭小型抗原结合探针。快速的生产和共轭,加上并行化的可能性以及通过显微镜进行精确分析,形成了一个出色的纳米抗体原型设计平台。本文所示方法可用于快速筛选和评估从例如噬菌体展示中获得的纳米抗体序列/克隆,用作共轭小分子载体。该程序可加速用于研究和药物应用的纳米抗体的生物工程。